| CASE REPORT |
|
| Year : 2013 | Volume
: 19
| Issue : 6 | Page : 286-289 |
|
|
Vanishing bile duct syndrome in a hodgkin's lymphoma patient with fatal outcome despite lymphoma remission
Aamer Aleem1, Mohammad Al-Katari1, Khalid Alsaleh1, Khalid AlSwat2, Abdulmalik Al-Sheikh3
1 Department of Medicine, Division of Hematology/Oncology, College of Medicine and King Khalid University Hospital, King Saud University, Riyadh, Saudi Arabia
2 Department of Gastroenterology, College of Medicine and King Khalid University Hospital, King Saud University, Riyadh, Saudi Arabia
3 Department of Department of Pathology, College of Medicine and King Khalid University Hospital, King Saud University, Riyadh, Saudi Arabia
Correspondence Address:
Aamer Aleem
Consultant Hematologist, Department of Medicine (38), King Khalid University Hospital, Riyadh 11472
Saudi Arabia
 Source of Support: None, Conflict of Interest: None  | Check |
DOI: 10.4103/1319-3767.121037
|
|
|
Vanishing bile duct syndrome (VBDS) is a condition resulting from severe bile duct injury, progressive destruction, and disappearance of intrahepatic bile ducts (ductopenia) leading to cholestasis, biliary cirrhosis, and liver failure. VBDS can be associated with a variety of disorders, including Hodgkin's lymphoma (HL). We describe a 33-year-old male patient who presented with lymphadenopathy and jaundice, and was diagnosed to have HL. Serum bilirubin worsened progressively despite chemotherapy, with a cholestatic pattern of liver enzymes. Diagnosis of VBDS was established on liver biopsy. Although remission from HL was achieved, the patient died of liver failure. Presence of jaundice in HL patients should raise the possibility of VBDS. This report discusses the difficulties of delivering chemotherapy in patients with liver dysfunction. HL-associated VBDS carries a high mortality but lymphoma remission can be achieved in some patients. Therefore, liver transplantation should be considered early in these patients. |
|
|
|
| [FULL TEXT] [PDF]* |
|
 |
|
Next article
